Vanguard Group’s Champions Oncology CSBR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.41M | Buy |
327,029
+19,155
| +6% | +$141K | ﹤0.01% | 3475 |
|
|
2025
Q1 | $2.67M | Buy |
307,874
+872
| +0.3% | +$7.57K | ﹤0.01% | 3391 |
|
|
2024
Q4 | $2.63M | Hold |
307,002
| – | – | ﹤0.01% | 3484 |
|
|
2024
Q3 | $1.5M | Hold |
307,002
| – | – | ﹤0.01% | 3646 |
|
|
2024
Q2 | $1.59M | Buy |
307,002
+221,398
| +259% | +$1.14M | ﹤0.01% | 3636 |
|
|
2024
Q1 | $419K | Buy |
85,604
+2,767
| +3% | +$13.6K | ﹤0.01% | 4058 |
|
|
2023
Q4 | $466K | Buy |
82,837
+14,157
| +21% | +$79.6K | ﹤0.01% | 4054 |
|
|
2023
Q3 | $427K | Buy |
68,680
+673
| +1% | +$4.18K | ﹤0.01% | 4104 |
|
|
2023
Q2 | $434K | Hold |
68,007
| – | – | ﹤0.01% | 4162 |
|
|
2023
Q1 | $273K | Hold |
68,007
| – | – | ﹤0.01% | 4270 |
|
|
2022
Q4 | $307K | Sell |
68,007
-267,608
| -80% | -$1.21M | ﹤0.01% | 4218 |
|
|
2022
Q3 | $2.52M | Sell |
335,615
-10,228
| -3% | -$76.7K | ﹤0.01% | 3656 |
|
|
2022
Q2 | $2.77M | Hold |
345,843
| – | – | ﹤0.01% | 3668 |
|
|
2022
Q1 | $2.81M | Buy |
345,843
+2,710
| +0.8% | +$22K | ﹤0.01% | 3809 |
|
|
2021
Q4 | $2.87M | Buy |
343,133
+15,497
| +5% | +$130K | ﹤0.01% | 3894 |
|
|
2021
Q3 | $3.35M | Hold |
327,636
| – | – | ﹤0.01% | 3873 |
|
|
2021
Q2 | $3.37M | Sell |
327,636
-136,906
| -29% | -$1.41M | ﹤0.01% | 3787 |
|
|
2021
Q1 | $5.25M | Buy |
464,542
+32,371
| +7% | +$366K | ﹤0.01% | 3508 |
|
|
2020
Q4 | $4.66M | Sell |
432,171
-213,991
| -33% | -$2.31M | ﹤0.01% | 3390 |
|
|
2020
Q3 | $5.98M | Buy |
646,162
+251,822
| +64% | +$2.33M | ﹤0.01% | 3061 |
|
|
2020
Q2 | $3.77M | Buy |
394,340
+107,515
| +37% | +$1.03M | ﹤0.01% | 3218 |
|
|
2020
Q1 | $2.12M | Buy |
286,825
+21,637
| +8% | +$160K | ﹤0.01% | 3290 |
|
|
2019
Q4 | $2.21M | Buy |
265,188
+66
| +0% | +$550 | ﹤0.01% | 3423 |
|
|
2019
Q3 | $1.5M | Hold |
265,122
| – | – | ﹤0.01% | 3537 |
|
|
2019
Q2 | $2.08M | Hold |
265,122
| – | – | ﹤0.01% | 3468 |
|
|
2019
Q1 | $2.6M | Buy |
265,122
+14,011
| +6% | +$137K | ﹤0.01% | 3368 |
|
|
2018
Q4 | $1.96M | Buy |
251,111
+19,961
| +9% | +$156K | ﹤0.01% | 3383 |
|
|
2018
Q3 | $4.04M | Buy |
231,150
+78,428
| +51% | +$1.37M | ﹤0.01% | 3315 |
|
|
2018
Q2 | $984K | Hold |
152,722
| – | – | ﹤0.01% | 3694 |
|
|
2018
Q1 | $553K | Buy |
152,722
+43,669
| +40% | +$158K | ﹤0.01% | 3767 |
|
|
2017
Q4 | $423K | Buy |
109,053
+21,169
| +24% | +$82.1K | ﹤0.01% | 3786 |
|
|
2017
Q3 | $323K | Buy |
87,884
+13,052
| +17% | +$48K | ﹤0.01% | 3832 |
|
|
2017
Q2 | $194K | Hold |
74,832
| – | – | ﹤0.01% | 3908 |
|
|
2017
Q1 | $236K | Buy |
74,832
+26,581
| +55% | +$83.8K | ﹤0.01% | 3880 |
|
|
2016
Q4 | $122K | Buy |
48,251
+32,411
| +205% | +$81.9K | ﹤0.01% | 3959 |
|
|
2016
Q3 | $27K | Buy |
+15,840
| New | +$27K | ﹤0.01% | 4061 |
|